Cargando…

White coat hypertension in pediatrics

The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurko, Alexander, Minarik, Milan, Jurko, Tomas, Tonhajzerova, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717664/
https://www.ncbi.nlm.nih.gov/pubmed/26786497
http://dx.doi.org/10.1186/s13052-016-0213-3
_version_ 1782410695394983936
author Jurko, Alexander
Minarik, Milan
Jurko, Tomas
Tonhajzerova, Ingrid
author_facet Jurko, Alexander
Minarik, Milan
Jurko, Tomas
Tonhajzerova, Ingrid
author_sort Jurko, Alexander
collection PubMed
description The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coat phenomenon and white coat hypertension. Children often attribute pain and other unpleasant experience to the white coat and refuse afterwards cooperation with examinations. Definition of white coat hypertension in the literature is not uniform. It has been defined as elevated blood pressure in the hospital or clinic with normal blood pressure at home measured during the day by ambulatory blood pressure monitoring system. White coat effect is defined as temporary increase in blood pressure before and during visit in the clinic, regardless what the average daily ambulatory blood pressure values are. Clinical importance of white coat hypertension is mainly because of higher risk for cardiovascular accidents that are dependent on end organ damage (heart, vessels, kidney). Current data do not allow any clear recommendations for the treatment. Pharmacological therapy is usually started in the presence of hypertrophic left ventricle, changes in intimal/medial wall thickness of carotic arteries, microalbuminuria and other cardiovascular risk factors. Nonpharmacological therapy is less controversial and certainly more appropriate. Patients have to change their life style, need to eliminate as much cardiovascular risk factors as possible and sustain a regular blood pressure monitoring.
format Online
Article
Text
id pubmed-4717664
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47176642016-01-20 White coat hypertension in pediatrics Jurko, Alexander Minarik, Milan Jurko, Tomas Tonhajzerova, Ingrid Ital J Pediatr Review The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coat phenomenon and white coat hypertension. Children often attribute pain and other unpleasant experience to the white coat and refuse afterwards cooperation with examinations. Definition of white coat hypertension in the literature is not uniform. It has been defined as elevated blood pressure in the hospital or clinic with normal blood pressure at home measured during the day by ambulatory blood pressure monitoring system. White coat effect is defined as temporary increase in blood pressure before and during visit in the clinic, regardless what the average daily ambulatory blood pressure values are. Clinical importance of white coat hypertension is mainly because of higher risk for cardiovascular accidents that are dependent on end organ damage (heart, vessels, kidney). Current data do not allow any clear recommendations for the treatment. Pharmacological therapy is usually started in the presence of hypertrophic left ventricle, changes in intimal/medial wall thickness of carotic arteries, microalbuminuria and other cardiovascular risk factors. Nonpharmacological therapy is less controversial and certainly more appropriate. Patients have to change their life style, need to eliminate as much cardiovascular risk factors as possible and sustain a regular blood pressure monitoring. BioMed Central 2016-01-15 /pmc/articles/PMC4717664/ /pubmed/26786497 http://dx.doi.org/10.1186/s13052-016-0213-3 Text en © Jurko et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Jurko, Alexander
Minarik, Milan
Jurko, Tomas
Tonhajzerova, Ingrid
White coat hypertension in pediatrics
title White coat hypertension in pediatrics
title_full White coat hypertension in pediatrics
title_fullStr White coat hypertension in pediatrics
title_full_unstemmed White coat hypertension in pediatrics
title_short White coat hypertension in pediatrics
title_sort white coat hypertension in pediatrics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717664/
https://www.ncbi.nlm.nih.gov/pubmed/26786497
http://dx.doi.org/10.1186/s13052-016-0213-3
work_keys_str_mv AT jurkoalexander whitecoathypertensioninpediatrics
AT minarikmilan whitecoathypertensioninpediatrics
AT jurkotomas whitecoathypertensioninpediatrics
AT tonhajzerovaingrid whitecoathypertensioninpediatrics